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Abstract 
 
Ivermectin has been widely acknowledged to cause neurotoxicity in chelonians even at a 
dose of 50 µg/kg body weight. Interestingly, another member of the macrocyclic lactone 
family namely milbemycin, did not induce any observable toxic effects when 
administered to chelonians at therapeutic doses.  However, injectable milbemycin is 
currently not available in the market and has to be prepared from technical grade 
materials. There is a need for injectable endo- and ecto-parasiticides that can be used 
safely in chelonians, which have a unique anatomy that makes it difficult to administer 
oral medication. The objective of this study was to determine whether or not doramectin 
given at twice the usual therapeutic dose (600 µg/kg body weight) will result in toxicity 
in the red-eared sliders. For this study, the sliders were distributed into 4 groups and 
doramectin was administered intramuscularly to the sliders according to dose group; low 
dose group (100 µg/kg body weight, n=4), medium dose group (300 µg/kg body weight, 
n=4), and a high dose group (600 µg/kg body weight, n=4), while the control group (n=4) 
was given 0.9% NaCl injections. They were monitored for signs of neurotoxicity, 
particularly paresis and paralysis for 4 weeks following doramectin administration. Blood 
samples were taken before treatment and at the conclusion of the study. The red-eared 
sliders were then humanely euthanised and samples of the liver and brain examined 
histopathologically. No clinical sign was observed throughout the 4-week study, and the 
blood results and histopathology did show significant findings. This indicates that 
doramectin can be used with no obvious adverse effects in red-eared sliders even at a 
high dose of 600 µg/kg body weight.  
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